Literature DB >> 25125677

Vancomycin plus ceftaroline shows potent in vitro synergy and was successfully utilized to clear persistent daptomycin-non-susceptible MRSA bacteraemia.

Katie E Barber1, Michael J Rybak2, George Sakoulas3.   

Abstract

Entities:  

Keywords:  combination therapy; haemodialysis; septic thrombophlebitis

Mesh：

Substances：

Year:  2014        PMID： 25125677     DOI： 10.1093/jac/dku322

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

1.  Multicenter Observational Study of Ceftaroline Fosamil for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.

Authors:  Evan J Zasowski; Trang D Trinh; Kimberly C Claeys; Anthony M Casapao; Noor Sabagha; Abdalhamid M Lagnf; Kenneth P Klinker; Susan L Davis; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2017-01-24       Impact factor: 5.191

Review 2.  Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections.

Authors:  Kyle C Molina; Vanthida Huang
Journal:  Curr Infect Dis Rep       Date:  2016-12       Impact factor: 3.725

3.  Combination of Tedizolid and Daptomycin against Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations.

Authors:  Jordan R Smith; Juwon Yim; Seth Rice; Kyle Stamper; Razie Kebriaei; Michael J Rybak
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

4.  Septic Thrombophlebitis with Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia and de Novo Resistance to Vancomycin and Daptomycin.

Authors:  Yael Koton; Zafrir Or; Naiel Bisharat
Journal:  Infect Dis Rep       Date:  2017-05-31

5.  Comparing the Outcomes of Ceftaroline Plus Vancomycin or Daptomycin Combination Therapy Versus Monotherapy in Adults with Complicated and Prolonged Methicillin-Resistant Staphylococcus Aureus Bacteremia Initially Treated with Supplemental Ceftaroline.

Authors:  Omar Ahmad; Timothy N Crawford; Thein Myint
Journal:  Infect Dis Ther       Date:  2019-11-28

6.  Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments.

Authors:  Erin K McCreary; Ravina Kullar; Matthew Geriak; Evan J Zasowski; Khulood Rizvi; Lucas T Schulz; Krista Ouellette; Logan Vasina; Fadi Haddad; Michael J Rybak; Marcus J Zervos; George Sakoulas; Warren E Rose
Journal:  Open Forum Infect Dis       Date:  2019-12-31       Impact factor: 3.835

7.  In Vitro Pharmacodynamic Analyses Help Guide the Treatment of Multidrug-Resistant Enterococcus faecium and Carbapenem-Resistant Enterobacter cloacae Bacteremia in a Liver Transplant Patient.

Authors:  Eric Wenzler; Maressa Santarossa; Kevin A Meyer; Amanda T Harrington; Gail E Reid; Nina M Clark; Fritzie S Albarillo; Zackery P Bulman
Journal:  Open Forum Infect Dis       Date:  2020-01-04       Impact factor: 3.835

8.  In Vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus.

Authors:  Vidya P Narayanaswamy; Scott A Giatpaiboon; John Uhrig; Paul Orwin; William Wiesmann; Shenda M Baker; Stacy M Townsend
Journal:  PLoS One       Date:  2018-01-17       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.